Rare diseases
Investigational molecules
Locations
Back to Germany1 491 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Efgartigimod for Adults with Thyroid Eye Disease
GermanyStudy on the Effectiveness and Safety of Intranasal BPL-003 for Patients with Treatment-Resistant Depression
GermanyStudy on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder
GermanyStudy on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal
GermanyStudy Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients
GermanyStudy on the Safety and Effects of Fasudil Hydrochloride for Patients with Parkinson's Disease
GermanyStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
GermanyLong-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
GermanyStudy Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer
GermanyStudy on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis
GermanyStudy on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
